Disable ads (and more) with a membership for a one time $4.99 payment
In which patient population is Flibanserin (Addyi) indicated?
Premenopausal females only
Postmenopausal females
All adults regardless of sex
Adolescents
The correct answer is: Premenopausal females only
Flibanserin (Addyi) is indicated in premenopausal females only. It is specifically approved by the FDA for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women. HSDD is characterized by a lack of sexual desire that causes distress or interpersonal difficulty. Flibanserin works by affecting neurotransmitters in the brain to help increase sexual desire. This medication is not indicated for postmenopausal females, all adults regardless of sex, or adolescents, as its safety and efficacy have not been established in these populations.